Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.45M Sell
13,235
-33
-0.2% -$3.66K 0.02% 491
2025
Q4
$1.47M Buy
13,268
+499
+4% +$55K 0.02% 462
2025
Q3
$1.43M Sell
12,769
-3,198
-20% -$336K 0.02% 467
2025
Q2
$1.68M Buy
15,967
+3,742
+31% +$393K 0.02% 411
2025
Q1
$1.36M Sell
12,225
-169
-1% -$17.9K 0.02% 462
2024
Q4
$1.28M Sell
12,394
-3,818
-24% -$416K 0.02% 480
2024
Q3
$1.83M Buy
16,212
+2,131
+15% +$217K 0.03% 376
2024
Q2
$1.25M Buy
14,081
+11,470
+439% +$986K 0.02% 440
2024
Q1
$224K Buy
2,611
+150
+6% +$12.3K 0.01% 600
2023
Q4
$203K Buy
+2,461
New +$198K 0.01% 584

Other funds holding AFL

Choreo LLC's AFL Position: Q1 2026 in Review

Choreo LLC reduced its Aflac (AFL) stake by 0.25% in Q1 2026, selling an estimated $3.66K and leaving 13,235 shares worth $1.45M. The position accounts for 0.02% of the portfolio, ranked #491.

Choreo LLC first reported a position in AFL in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.83M in Q3 2024. 1,653 funds tracked by Wall St. Rank hold AFL as of Q1 2026.

  • Choreo LLC held 13,235 shares of Aflac worth $1.45M as of Q1 2026.
  • Choreo LLC sold 33 Aflac shares in Q1 2026, an estimated $3.66K.
  • Aflac made up 0.02% of Choreo LLC's portfolio in Q1 2026, its #491 holding.
  • Choreo LLC first reported a position in Aflac in Q4 2023 and has held it in 10 quarters since.
  • Choreo LLC's Aflac position peaked at $1.83M in Q3 2024.
  • 1,653 funds tracked by Wall St. Rank held Aflac as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.